Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0229353dc0ef6d70d96e6bb2cea7cd40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0af73ecc98a68f6e2e6a7b28f029ef52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a43c3a83bacec45ece61276d9c8b27e5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96494 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a7c1d8f3384dc4ef5213319146a449d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_323fd7c67b37f12fd2aec4a6df4a4090 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33b6fd2aa927454b575cd5d7a9228b4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c661e3c51694c43cb97ce4973a5d72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66b9a885691f951ddd885b4defbdfb96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_938301a4027647c91789faa52b57cc2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_758fd59c02ebd6c8bf22bb73ddea5839 |
publicationDate |
2019-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2019016400-A1 |
titleOfInvention |
CTNB1 AS A MARKER FOR CANCER OF THE ENDOMETER |
abstract |
The present invention relates to a method for diagnosis and prognosis of endometrial cancer in easily accessible isolated samples by detecting the level of expression of one or more proteins. In particular, from uterine fluid samples. The invention also relates to kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease. |
priorityDate |
2017-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |